Avivagen Inc. (VIV:CA)

What Can the Completion of Safety Studies Mean?


Joe GomesMedia Inquiries
Senior Generalist Equity Analyst
June 10, 2022
Report ID: 25104
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.


Avivagen Inc.
Avivagen Inc.
Healthcare
Drug Manufacturers
Ticker
VIV:CA
Current Price
$0.06 -14.29%
Market Cap
$4.6M
Price Target
Refer to Report
Volume
63.5K
52wk Range
$0.06 - $0.4
Related Research Reports
10/25/2022

Securing More Financing
Securing More Financing (VIV:CA)
9/20/2022

Slower Quarter but Increasing Activity
Slower Quarter but Increasing Activity (VIV:CA)
8/5/2022

AB Vista Gets on the Board
AB Vista Gets on the Board (VIV:CA)
8/1/2022

Getting New Sales
Getting New Sales (VIV:CA)

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2022 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.